On December 6, U.S. District Judge for the Southern District of Florida, Judge Robin L. Rosenberg granted summary judgment in favor of defendants Pfizer, Boehringer Ingelheim, GlaxoSmithKline (GSK) and Sanofi, in MDL 2924 – In Re: Zantac (Ranitidine) Products...
The United States Judicial Panel on Multidistrict Litigation (JPML) will convene a hearing session in New York on December 1 to consider the consolidation and transfer of 11 lawsuits filed in six federal districts to the United States District Court for the District...
On August 4, 2022, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated claims related to the use of the Gardasil vaccine before Judge Robert J. Conrad, Jr. of the U.S. District Court for the Western District of North Carolina. Manufactured by Merck...
On June 10, 2022, a motion to transfer pursuant to 28 U.S.C. Sec. 1407 was filed with the Judicial Panel on Multidistrict Litigation (JPML). Titled In Re: Acetaminophen- ASD/ADHD Product Liability Litigation, the motion seeks to transfer 19 cases for coordination of...
On February 25, generic opioid manufacturer Johnson and Johnson and three major pharmaceutical distributors finalized a $26 billion deal that will settle around 3000 lawsuits filed by state and local governments in the ongoing opioid litigation, some of which have...
On December 30, after a six months-long trial, a New York jury found that Teva Pharmaceuticals contributed to the opioid crisis by creating a public nuisance in Suffolk and Nassau counties and New York State. Attributing 90% of the liability to Teva and its Anda Inc....
On December 16, U.S. District Judge Colleen McMahon issued a 142-page opinion ruling on the appeal brought by opponents to the Purdue Bankruptcy Plan that was approved in September, 2021 by Judge Robert D. Drain of the U.S. Bankruptcy Court for the Southern District...
Multiple appeals have been filed in the Purdue Pharma Chapter 11 bankruptcy case, centering on the issue of the releases being given to the members of the Sackler family that own Purdue. On September 21, United States Trustee William K. Harrington filed a motion...
In a major development in the ongoing opioid litigation involving the State of New York and Nassau and Suffolk counties, on September 9 defendant manufacturer Endo Pharmaceuticals settled for $50 million. Endo reached the settlement amidst allegations that the company...
There have been a number of developments on the opioid litigation front in the last week. Drugmaker Endo Pharmaceuticals and its lawyers from Arnold & Porter are battling allegations that they withheld damaging evidence from the parties by failing to respond to...
888-681-1129